亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ale完成签到,获得积分10
14秒前
干净书双完成签到,获得积分10
17秒前
李健应助Shining_Wu采纳,获得30
23秒前
Kao应助科研通管家采纳,获得10
23秒前
思源应助科研通管家采纳,获得10
23秒前
hyishu完成签到,获得积分10
25秒前
羊咩咩完成签到,获得积分20
27秒前
30秒前
安静惋清完成签到,获得积分10
37秒前
53秒前
刘刘完成签到 ,获得积分10
54秒前
Shining_Wu发布了新的文献求助30
57秒前
level完成签到 ,获得积分10
1分钟前
冷艳凡灵完成签到,获得积分10
1分钟前
ZYP完成签到,获得积分10
1分钟前
悦耳的城完成签到,获得积分10
1分钟前
不期完成签到 ,获得积分10
1分钟前
bai完成签到 ,获得积分10
1分钟前
xiaomage完成签到,获得积分10
1分钟前
科研通AI6.2应助Logan采纳,获得10
1分钟前
热心荆完成签到,获得积分10
1分钟前
健忘初露完成签到,获得积分10
2分钟前
Shu完成签到,获得积分10
2分钟前
刻苦的煎蛋完成签到,获得积分10
2分钟前
ssgg完成签到,获得积分10
2分钟前
2分钟前
Kao应助科研通管家采纳,获得10
2分钟前
不爱写论文完成签到,获得积分10
2分钟前
坚定谷蕊完成签到,获得积分10
2分钟前
Logan发布了新的文献求助10
2分钟前
cy完成签到 ,获得积分10
2分钟前
Lynee完成签到,获得积分10
2分钟前
Jasper应助xiaomage采纳,获得10
2分钟前
小辣椒完成签到,获得积分10
2分钟前
多情的涔完成签到,获得积分10
2分钟前
zhangwenkang完成签到,获得积分10
2分钟前
zhaodan完成签到,获得积分10
2分钟前
guyuzheng完成签到,获得积分10
2分钟前
爱听歌谷蓝完成签到,获得积分10
3分钟前
魔幻的芳完成签到,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Rosenblum, Global Change Biology 800
自動車の空力技術 800
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7778032
求助须知:如何正确求助?哪些是违规求助? 9318730
关于积分的说明 20365594
捐赠科研通 7365134
什么是DOI,文献DOI怎么找? 3319154
关于科研通互助平台的介绍 2466886
邀请新用户注册赠送积分活动 2334449